FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2943889580> ?p ?o ?g. }

• W2943889580 endingPage "2837" @default.
• W2943889580 startingPage "2826" @default.
• W2943889580 abstract "A glutathione-sensitive poly[methacrylic acid- co-poly(ethylene glycol) methyl ether methacrylate] (PMAABACy- co-PEGMA) nanogel with tunable stability has been fabricated through covalent and metal double-cross-linking strategies in response to the differential change of GSH concentration between the inside and outside of tumor cells. Herein, the size-controlled PMAA- co-PEGMA that possessed unique core-shell structure was first obtained via adjusting the length of PEGMA. Furthermore, N, N-bis(acryloyl)cystamine was introduced to endow PMAA- co-PEGMA with glutathione-sensitive property. The PMAABACy- co-PEGMA950 nanogel exhibited reasonable particle size and desired hydrodynamic diameter that was further cross-linked by Fe(III) ions to obtain a double-cross-linked PMAABACy/Fe(III)- co-PEGMA950 vehicle. In this double-cross-linked vehicle, the existence of metal cross-linked structure made this vehicle possess favorable structural stability to restrict the premature leakage of therapeutic drug. The introduction of covalent cross-linked structure synchronously imparted the vehicle with glutathione-sensitive property in response to the high intracellular glutathione concentrations in tumor cells to induce its structural transform for realizing the release of drug. Additionally, a series of in vitro evaluations demonstrated that PMAABACy/Fe(III)- co-PEGMA950 displayed remarkable biocompatibility and glutathione-sensitive release toward anticancer drug in the simulated intracellular environment of tumor tissues. Notably, the drug-loaded PMAABACy/Fe(III)- co-PEGMA950 exhibited excellent anticancer activity against tumor cells. The double-cross-linked PMAABACy/Fe(III)- co-PEGMA950 nanogel therefore is expected to be a promising tumor microenvironment-sensitive platform for delivering chemotherapeutic drugs." @default.
• W2943889580 created "2019-05-16" @default.
• W2943889580 creator A5029004987 @default.
• W2943889580 creator A5070287521 @default.
• W2943889580 date "2019-05-07" @default.
• W2943889580 modified "2023-09-24" @default.
• W2943889580 title "Glutathione-Induced Structural Transform of Double-Cross-Linked PEGylated Nanogel for Efficient Intracellular Anticancer Drug Delivery" @default.
• W2943889580 cites W1765690317 @default.
• W2943889580 cites W1963674712 @default.
• W2943889580 cites W1971479823 @default.
• W2943889580 cites W1982461928 @default.
• W2943889580 cites W1983247405 @default.
• W2943889580 cites W1995565650 @default.
• W2943889580 cites W1998700258 @default.
• W2943889580 cites W2028362286 @default.
• W2943889580 cites W2034365540 @default.
• W2943889580 cites W2035565668 @default.
• W2943889580 cites W2044008891 @default.
• W2943889580 cites W2053095627 @default.
• W2943889580 cites W2053890812 @default.
• W2943889580 cites W2070143299 @default.
• W2943889580 cites W2075387097 @default.
• W2943889580 cites W2079026188 @default.
• W2943889580 cites W2084527868 @default.
• W2943889580 cites W2103650142 @default.
• W2943889580 cites W2107529389 @default.
• W2943889580 cites W2114001610 @default.
• W2943889580 cites W2129049149 @default.
• W2943889580 cites W2129490603 @default.
• W2943889580 cites W2140558679 @default.
• W2943889580 cites W2162750459 @default.
• W2943889580 cites W2166280494 @default.
• W2943889580 cites W2272984102 @default.
• W2943889580 cites W2306471161 @default.
• W2943889580 cites W2346674701 @default.
• W2943889580 cites W2512843523 @default.
• W2943889580 cites W2570618306 @default.
• W2943889580 cites W2583475973 @default.
• W2943889580 cites W2749073589 @default.
• W2943889580 cites W2784486430 @default.
• W2943889580 cites W2804155641 @default.
• W2943889580 cites W2804171785 @default.
• W2943889580 cites W2889025381 @default.
• W2943889580 cites W2901016018 @default.
• W2943889580 cites W2904307108 @default.
• W2943889580 doi "https://doi.org/10.1021/acs.molpharmaceut.9b00467" @default.
• W2943889580 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31063382" @default.
• W2943889580 hasPublicationYear "2019" @default.
• W2943889580 type Work @default.
• W2943889580 sameAs 2943889580 @default.
• W2943889580 citedByCount "19" @default.
• W2943889580 countsByYear W29438895802020 @default.
• W2943889580 countsByYear W29438895802021 @default.
• W2943889580 countsByYear W29438895802022 @default.
• W2943889580 countsByYear W29438895802023 @default.
• W2943889580 crossrefType "journal-article" @default.
• W2943889580 hasAuthorship W2943889580A5029004987 @default.
• W2943889580 hasAuthorship W2943889580A5070287521 @default.
• W2943889580 hasConcept C109316439 @default.
• W2943889580 hasConcept C12554922 @default.
• W2943889580 hasConcept C134424308 @default.
• W2943889580 hasConcept C166940927 @default.
• W2943889580 hasConcept C178790620 @default.
• W2943889580 hasConcept C180577832 @default.
• W2943889580 hasConcept C181199279 @default.
• W2943889580 hasConcept C185592680 @default.
• W2943889580 hasConcept C202751555 @default.
• W2943889580 hasConcept C21951064 @default.
• W2943889580 hasConcept C2775968528 @default.
• W2943889580 hasConcept C2777230088 @default.
• W2943889580 hasConcept C2777516009 @default.
• W2943889580 hasConcept C2779820397 @default.
• W2943889580 hasConcept C2781159505 @default.
• W2943889580 hasConcept C521977710 @default.
• W2943889580 hasConcept C538909803 @default.
• W2943889580 hasConcept C55493867 @default.
• W2943889580 hasConcept C79879829 @default.
• W2943889580 hasConcept C86803240 @default.
• W2943889580 hasConceptScore W2943889580C109316439 @default.
• W2943889580 hasConceptScore W2943889580C12554922 @default.
• W2943889580 hasConceptScore W2943889580C134424308 @default.
• W2943889580 hasConceptScore W2943889580C166940927 @default.
• W2943889580 hasConceptScore W2943889580C178790620 @default.
• W2943889580 hasConceptScore W2943889580C180577832 @default.
• W2943889580 hasConceptScore W2943889580C181199279 @default.
• W2943889580 hasConceptScore W2943889580C185592680 @default.
• W2943889580 hasConceptScore W2943889580C202751555 @default.
• W2943889580 hasConceptScore W2943889580C21951064 @default.
• W2943889580 hasConceptScore W2943889580C2775968528 @default.
• W2943889580 hasConceptScore W2943889580C2777230088 @default.
• W2943889580 hasConceptScore W2943889580C2777516009 @default.
• W2943889580 hasConceptScore W2943889580C2779820397 @default.
• W2943889580 hasConceptScore W2943889580C2781159505 @default.
• W2943889580 hasConceptScore W2943889580C521977710 @default.
• W2943889580 hasConceptScore W2943889580C538909803 @default.
• W2943889580 hasConceptScore W2943889580C55493867 @default.
• W2943889580 hasConceptScore W2943889580C79879829 @default.
• W2943889580 hasConceptScore W2943889580C86803240 @default.

• next